Wells Fargo & Company Amarin Corp Plcuk Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Wells Fargo & Company holds 53,166 shares of AMRN stock, worth $39,342. This represents 0.0% of its overall portfolio holdings.
Number of Shares
53,166
Previous 55,406
4.04%
Holding current value
$39,342
Previous $48,000
2.08%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding AMRN
# of Institutions
183Shares Held
87.9MCall Options Held
528KPut Options Held
219K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$18.4 Million3.87% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12MShares$8.9 Million1.12% of portfolio
-
Dg Capital Management, LLC New York, NY6.44MShares$4.77 Million3.54% of portfolio
-
Eversept Partners, LP New York, NY6.21MShares$4.6 Million0.42% of portfolio
-
Morgan Stanley New York, NY3.61MShares$2.67 Million0.0% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $298M
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...